User login
Funding through the National Heart, Lung, and Blood Institute’s VITA program is now available for those developing an innovative technology for treatment of vascular disorders or thrombotic diseases. VITA is a contract program supporting translational research projects that address unmet needs in vascular disorders, thrombotic diseases, and pulmonary hypertension. Responses are due Oct. 8, 2015. Apply for funding through this program by October 8, 2015.
Funding through the National Heart, Lung, and Blood Institute’s VITA program is now available for those developing an innovative technology for treatment of vascular disorders or thrombotic diseases. VITA is a contract program supporting translational research projects that address unmet needs in vascular disorders, thrombotic diseases, and pulmonary hypertension. Responses are due Oct. 8, 2015. Apply for funding through this program by October 8, 2015.
Funding through the National Heart, Lung, and Blood Institute’s VITA program is now available for those developing an innovative technology for treatment of vascular disorders or thrombotic diseases. VITA is a contract program supporting translational research projects that address unmet needs in vascular disorders, thrombotic diseases, and pulmonary hypertension. Responses are due Oct. 8, 2015. Apply for funding through this program by October 8, 2015.
